Enterprise Value
-5.113M
Cash
28.87M
Avg Qtr Burn
-3.003M
Short % of Float
1.58%
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
LPCN1144 Details Non-alcoholic steatohepatitis | Phase 3 Update | |
LPCN1107 Details Preterm birth | Phase 3 Update | |
LPCN 1154 Details Postpartum depression | Phase 3 Initiation | |
LPCN 1148 Details Cirrhosis | Phase 2 Data readout |